In a study involving data from thousands of people, the risk of a new coronary heart disease diagnosis was statistically associated with bloodstream levels of nine specific molecules that are produced ...

For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain ...

Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the ...

(NASDAQ:IBIO), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today ...

Study could lead to an effective new option to reduce the risk of heart attacks and strokes for millions who cannot control ...

A diet focused on the best foods for brain health slowed aging in key parts of the brain by over 2 years, a new study found.

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

Eating a combination of two award-winning diets slowed aging in key structures inside the brain by over two years, according ...

Well, it is what AI recommended for one.If a teen is interested in losing weight, chances are they may turn to artificial ...

Researchers found that the risk of type 2 diabetes varies among young adults. Those with high fasting glucose who qualified for GLP-1 treatment had a higher risk of type 2 diabetes, suggesting that ...

Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript March 17, 2026 Longeveron Inc. beats earnings expectations.

Capital Infusion -- $15.9 million raised from Coastland Capital and Janus Henderson through a private placement, with a potential additional $15 million tranche contingent on milestone achievement.